Table 2.
Flavonoid Subclass | Name of Flavonoid | Metabolites Produced by Gut Microbiota | Type of Cancer (s) | Targeted Pathways | Mechanism of Action | Methods of Testing | Model Used | References | |
---|---|---|---|---|---|---|---|---|---|
In Vivo | In Vitro | ||||||||
Flavonol | 1. Rutin | Quercetin -3- O- glucoside Quercetin |
Colorectal cancer Colonic adenocarcinoma |
Reactive oxygen species (ROS) Apoptosis Angiogenesis |
Inhibit tumor cell proliferation Impaired attachment of cells in dose-dependent matter (38 ± 1.9%) Inhibit cell migration Protect cells from inflammation, oxidative stress, and DNA damage |
Cell viability assay Cell migration assay Adhesion assay Haptotaxis assay |
Azoxymethane (AOM) treated mice | Caco-2 cells HT29 cells |
[107,108,109] |
2. Fisetin | No available data | Gastric cancer Colorectal cancer |
Apoptosis Caspase -7 B-cell lymphoma 2 (Bcl-2) |
Reduce cellular proliferation significantly Reduce anti-apoptotic proteins Reduce the activation of extracellular- signal-regulated kinase ½ in dose- dependent matter Increase the proportion of cells at G2/M phase Increase the level of caspase 7 Induce cellular apoptosis (87% after treatment) |
Flow cytometry Western blot Cell counting kit-8 assay Immunoblotting |
Apc Min/+ males Wistar rats |
SGC7901 cells PIK3CA cells |
[110] | |
3. Kaempferol | Kaempferol -3-O- glucoside p-coumaric acid kaempferol 3-(4 hydroxyphenyl) propionic acid 3-phenylpropionic acid |
Gastric cancer Colorectal cancer |
B-cell lymphoma 2 (Bcl-2) Protein kinase B (Akt) Cyclooxygenase-2 |
Inhibit cellular proliferation significantly Inhibit the growth of tumor xenograft Reduce the expression level of cyclin B, Cyclin-dependent kinase 1 and cdc25c phosphatase Reduce the expression of Bcl-2 Increase the proportion of cells at G2/M phase Increase the level of caspase 3 and 9 * Induce cellular apoptosis |
Cell viability assay Western blot Tumor xenograft experiment Ki-67 immunochemistry |
Mice | SGC7901 cells MKN28 cells |
[111,112] | |
4. Quercetin | 3,4-dihydroxyphenylacetic acid 3-(3-hydroxyphenyl) propionic acid 3,4-dihydroxybenzoic 4-hydroxybenzoic acid |
Gastric cancer | Nuclear factor kappa (NF-κB) Protein kinase B (Akt) AMP-activated protein kinase |
Inhibit NF-κB, AMPKA pathways Reduce matrix metalloproteinases Reduce cellular migration and invasion Reduce tumor metastasis Induce cellular apoptosis |
Cell viability assay Western blot Flow cytometry Quantitative reverse transcription PCR |
Mice | AGS cells GCBGC823 cells MGC803 cells |
[113,114] | |
5. Isorhamnetin | 3-O-neohesperidoside Isorhamnetin -3- glucoside Aglycone isorhamnetin |
Gastric cancer Colorectal cancer |
Protein kinase B (Akt) Phosphoinositide 3-kinase Peroxisome proliferator-activated receptor gamma (PPAR-γ) |
Inhibit cellular proliferation Reduce the expression of anti-apoptotic proteins Reduce cellular invasion Induce cellular apoptosis Increase PPAR-γ expression |
PPAR-γ competition assay Flow cytometry Western blot Invasion assay |
Mice | AGS cells MKN45 cells |
[115,116] | |
6. Morin | Morin glucuronides Morin sulfates |
Colorectal cancer | Peroxisome proliferator-activated receptor gamma (PPAR-γ) Nuclear factor kappa (NF-κB) B-cell lymphoma 2 (Bcl-2) |
Inhibit cellular proliferation in dose and time dependent matter Inhibit NF-κB, AMPKA pathways Reduce glucose uptake Reduce antioxidant activities Reduce ATP production level Induce cellular apoptosis Increase PPAR-γ expression |
Cell viability assay Flow cytometry Immunoblotting Antioxidant assay |
SW480 cells | [117,118] | ||
Flavanones | 7. Hesperidin | Hesperetin | Gastric cancer | Mitochondrial pathway (increase ROS) B-cell lymphoma 2 (Bcl-2) Cytochrome c specificity protein 1 (Sp1) Phosphatase and tensin homolog |
Inhibit cellular proliferation in dose and time dependent matter Inhibit xenograft tumor Reduce the expression of Bcl-2 Supress mRNA/protein level of Sp1 Reduce ATP production level Induce cellular apoptosis through PTEN expression Increase cytochrome c, caspase 3 and 9 expression |
Cell viability assay Western blot Transwell invasion assay Antibody studies |
Mice | SGC-7901cells MGC-803 cells HGC-27 cells |
[119,120] |
8. Naringenin | Aglycone naringenin | Gastric cancer Colorectal cancer |
B-cell lymphoma 2 (Bcl-2) Cyclin D1 protein Prostaglandin-endoperoxide synthase 2 (COX-2) |
Inhibit cellular proliferation in dose and time dependent matter Reduce cellular migration and invasion Reduce the expression of Bcl-2 Reduce cyclin D1 protein Induce cellular apoptosis Increase the level of cleaved caspase |
Quantitative reverse transcription PCR Western blot Proliferating cell nuclear antigen (PCNA) |
Azoxymethane (AOM) treated rats Wistar rats |
SGC-7901cells SW480 cells HCT-116 cells |
[121,122] | |
9. Eriodictyol | Eriocitrin | Colorectal cancer | β-glucuronidase Lipid peroxidation Superoxide dismutase (SOD) catalase (CAT) |
Supress cellular proliferation Reduce lipid peroxidation levels Reduce aberrant crypt foci Reduce microbial enzymatic activities in feces Reduce Argyrophilic nucleolar organizer region (AgNOR) Induce cellular apoptosis Increase the level of cleaved caspase |
AgNOR staining Bacterial enzymes assay Lipid peroxidation Histopathological assays |
Albino wistar rats | [123] | ||
Isoflavones | 10. Genistein | Dihydrogenistein 6-hydroxy-O-desmethylangolensin 2-(4-hydroxyphenyl) propionic acid |
Gastric cancer Colorectal cancer |
Protein kinase B (Akt) Notch1 signaling E-cadherins Nuclear factor kappa (NF-κB) |
Blocked high cell migration capacity of CD44 Reduce Glil and CD44 expression Supress cellular invasion and metastasis Decrease epithelial-mesenchymal transition (EMT) expression Inhibit Notch1 and NF-κB expression Induce cellular apoptosis Increase E-cadherins and caspase 3 expression |
Colony formation assay Western blot Flow cytometry Real time polymerase chain reaction Immunofluorescence |
MKN 45 cells HT-29 cells HCT-116 cells |
[124,125] | |
11. Daidzein | Dihydrodaidzein O-desmethylangolensin S- equol |
Colorectal cancer Choriocarcinoma |
Peroxisome proliferator-activated receptor gamma (PPAR-γ) Extracellular-signal-regulated kinase (P-ERK) |
Reduce lipid droplet accumulation Reduce Phosphoinositide 3-kinase (PI3K) expression Inhibit cellular proliferation Reduce the expression of P-ERK Induce cellular apoptosis Induce m-RNA expression of PPAR-γ |
Colony formation assay Western blot Flow cytometry Real time polymerase chain reaction Immunofluorescence |
Nude mice | JAR cells JEG-3 cells HT-29 cells |
[126] | |
Anthocyanins | 12. Cyanidin | Cyanidin-3- glucoside | Gastric adenocarcinoma | Combined activity of bacteria and host enzymes | Reduce cellular proliferation Induce cellular apoptosis through caspase-3 activation |
Cell viability assay High-performance liquid chromatography (HPLC) |
AGS cells | [127] | |
13. Delphinidin | Gallic acids | Colorectal cancer | αV/β3-integrin miR-204-3p |
Inhibit colony formation Reduce cellular viability (not significant) Inhibit migration and invasion through αV/β3-integrin reduction and miR-204-3p enhancement |
Colony formation assay Western blot Flow cytometry Microarray |
BALB/C nude mice | SW480 cells SW620 cells |
[128] | |
14. Pelargonidin | 4-hydroxybenzoic | Colorectal cancer | Apoptotic pathway | Reduce the expression of Bcl-2 Induce cellular apoptosis through intrinsic pathway Induce the loss of mitochondrial membrane potential |
Cell viability assay Western blot |
HT-29 cells | [129] | ||
Flavones | 15. Baicalein | Baicalein | Gastric cancer Colorectal cancer |
Inhibitory cell cycle proteins E-cadherins epithelial-mesenchymal transition (EMT) |
Supress cellular proliferation, migration and invasion in dose and time dependent matter Decrease the expression of EMT Induce cellular apoptosis Increase the expression of E- cadherins Increase the level of cell cycle inhibitory proteins (P53 and P21) |
Flow cytometry Western blot Cell counting kit-8 assay Transwell assay Colony formation assay Real time polymerase chain reaction |
Mice | SGC-7901cells SW480 cells HCT-116 cells HT-29 cells |
[130,131] |
16. Luteolin | No available data | Gastric cancer Colorectal cancer |
E-cadherins epithelial-mesenchymal transition (EMT) Protein kinase B (Akt) Mechanistic target of rapamycin (mTOR) Notch1 signaling |
Reduce cellular viability in time and dose dependent matter Inhibit cellular proliferation, migration and invasion Reduce aberrant crypt foci Decrease the expression of EMT by increasing E-cadherins and decreasing Notch1 signaling Induce cellular apoptosis |
Flow cytometry Western blot Cell viability assay Xenograft assay |
Mice | SGC-7901cells MKN 45 cells BGC-832 cells |
[132,133] | |
17. Diosmin | Diosmetin | Colorectal cancer | No available data | Inhibit aberrant crypt foci Reduce cellular proliferation |
Histopathological assays Microscopic evaluation |
Azoxymethane (AOM) treated rats | [134] | ||
18. Apigenin | Apigenin 3-(4-hydroxyphenyl) propionic acid |
Gastric cancer Colorectal cancer |
β-catenin B-cell lymphoma 2 (Bcl-2) |
Reduce mitochondrial membrane potential Inhibit cellular proliferation Reduce the expression of Bcl-2 Increase the expression of caspase 3 Induce cellular apoptosis through intrinsic and extrinsic pathways |
Flow cytometry Western blot Cell viability assay Real time polymerase chain reaction |
SGC-7901cells HCT-116 cells HGC-27 cells |
[135,136] | ||
19. Tangeretin | Tangeretin-O-glucuronides | Gastric cancer | Notch1 signaling | Reduce cellular viability, invasion and migration Inhibit Notch1 signaling pathway Decrease the expression of EMT by increasing E-cadherins Increase caspase 3 and 9 expression Induce cellular apoptosis through intrinsic and extrinsic pathways |
Flow cytometry Western blot Cell viability assay Microarray |
Nude mice | AGS cells MKN-45 cells MGC 80-3 cells |
[137,138] | |
20. Wogonin | Wogonin | Gastric cancer Colorectal cancer |
P53 translocation | Reduce tumor multiplicity Induce cellular apoptosis through increase endoplasmic reticulum stress |
Flow cytometry Western blot Cell viability assay Real time polymerase chain reaction |
Azoxymethane (AOM) treated mice | HCT-116 cells | [139,140] | |
21. Chrysin | Gastric cancer Colorectal cancer |
Nuclear factor kappa (NF-κB) SALL-4 Early growth response 1 (Egr1) |
Reduce tumor volume by downregulating SALL-4 expression Reduce cellular proliferation Supress the expression of NF-κB and Egr1 Increase caspase 3 and 9 expression Induce cellular apoptosis through intrinsic pathway (caspase 3 and 9) |
Flow cytometry Western blot Cell viability assay Quantitative reverse transcription PCR Apoptotic assays |
BALB/mice | HT-29 cells CT-26 cells |
[141] |